Isis Pharmaceuticals changed its name to Ionis Pharmaceuticals Friday, deciding it didn't want to share a name with a terrorist group.
Ionis now will trade on the Nasdaq Global Select Market under the ticker symbol IONS, replacing ISIS, effective when the market opens Tuesday. The company's new website is www.ionispharma.com
The company is focused on bringing its late-stage Phase 3 drugs -- nusinersen, volanesorsen an...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In